Dr. Steven M. Dubinett MD
Institution Name:
Total Awards:
1
Award Value:
$10,955,315
Awards as PI
| Program Type | Institution | Grant Title | Award Value |
|---|---|---|---|
| Clinical Trial Stage Projects | University of California, Los Angeles | A phase I trial of intratumoral administration of CCL21-gene modified dendritic cell (DC) combined with intravenous pembrolizumab for advanced NSCLC | $10,955,315 |
| Total: $10,955,315.00 |